Suriya Keeratichananont, Kamonwon Cattapan, Jintaporn Heebpet, Siriporn Leelakiatpaiboon, Nisa Netinatsunton
{"title":"Magnetic Resonance Defecography Criteria for the Diagnosis of Dyssynergic Defecation.","authors":"Suriya Keeratichananont, Kamonwon Cattapan, Jintaporn Heebpet, Siriporn Leelakiatpaiboon, Nisa Netinatsunton","doi":"10.5056/jnm26025","DOIUrl":"10.5056/jnm26025","url":null,"abstract":"<p><strong>Background/aims: </strong>: Evidence regarding the diagnostic value of MR defecography (MRD) for confirming dyssynergic defecation (DD) is limited. We aim to evaluate the diagnostic performance of MRD parameters in identifying patients with DD.</p><p><strong>Methods: </strong>: This retrospective study was conducted at a university hospital. Data from 235 consecutive adult patients with chronic primary constipation who underwent high-resolution anorectal manometry (HR-ARM), balloon expulsion test, and MRD between 2020 and 2024 were analyzed. The diagnostic performance of each dynamic MRD parameter was assessed using HR-ARM combined with balloon expulsion test as the reference standard.</p><p><strong>Results: </strong>: A total of 109 participants (86 females; mean age 53.1 ± 15.3 years) were included, of whom 70 patients (64.2%) were diagnosed with DD. Quantitative dynamic MRD parameters, including the M-line, anorectal angle (ARA), and anal canal width (ACW), demonstrated significantly good discriminatory ability for differentiating patients with DD (all <i>P</i> < 0.05). At cutoff values of 2.0 cm for the M-line at defecation combined with prominent puborectalis muscle or abnormal evacuation of contrast during defecation, 1.6 cm for M-line change, 114° for ARA at defecation, -5° for ARA change, and 10 mm for ACW during defecation, these parameters demonstrated acceptable diagnostic performance, achieving optimal specificities (82.1% to 92.3%), positive likelihood ratios (3.66 to 7.06), and diagnostic odds ratios (8.25 to 14.25). Multivariate analysis identified ARA and ACW at defecation as independent diagnostic predictors of DD (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>: These findings support the establishment of practical and reliable MR defecography-based diagnostic criteria for patients with dyssynergic defecation.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":" ","pages":"587-596"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148794383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Development of a Simplified Clinical Score for Defecation Disorder.","authors":"Tanawat Geeratragool, Monthira Maneerattanaporn, Pritsana Chuenprapai, Somchai Leelakusolvong, Thammanard Charernboon","doi":"10.5056/jnm25143","DOIUrl":"10.5056/jnm25143","url":null,"abstract":"<p><strong>Background/aims: </strong>: Defecation disorder (DD) is typically unresponsive to standard laxative therapy. Biofeedback is the treatment of choice, but diagnosis relies on physiological tests such as anorectal manometry (ARM), which are not widely accessible. This study aims to develop a clinical diagnostic score for DD using routinely assessed clinical features.</p><p><strong>Methods: </strong>: This retrospective study included 402 patients with refractory constipation in the derivation cohort and 100 patients in the validation cohort. All patients underwent ARM and balloon expulsion test. Predictive variables were identified by logistic regression and converted into an integer-based scoring system. Diagnostic performance was evaluated by area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, predictive values and likelihood ratios.</p><p><strong>Results: </strong>: DD was diagnosed in 52.5% of the derivation cohort (mean age 52.4 years; 82.1% female). Six independent predictors were identified and incorporated into an 11-point score, termed the STRAIN score: straining (adjusted odds ratio [aOR] 7.76, 3 points), 3 or more bowel movements per week (aOR 4.67, 2 points), rectal blockage sensation (aOR 3.71, 2 points), assisted defecation/manual maneuvers (aOR 2.55, 2 points), incomplete evacuation (aOR 1.95, 1 point), and new-onset symptoms ≤2 years (aOR 1.88, 1 point). The score showed AUROC values of 0.91 in the derivation and 0.88 in the validation cohort. A cutoff score of ≥6 provided 87.2% sensitivity, 83.2% specificity, 85.2% positive predictive value, and 85.5% negative predictive value.</p><p><strong>Conclusions: </strong>: This simple and accurate clinical score provides a practical tool for recognizing DD and may support early diagnosis and intervention in patients with refractory constipation.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":"32 4","pages":"597-606"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Functional Dyspepsia and Mortality Risk: Caution in Extrapolating From Claims-Based Evidence.","authors":"Jung-Hwan Oh, Moo In Park","doi":"10.5056/jnm26119","DOIUrl":"10.5056/jnm26119","url":null,"abstract":"","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":"32 4","pages":"700-701"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Juan S Hernández, Albis C Hani, Oscar M Muñoz, Juan P Garcia, Raúl A Cañadas, Freddy A Ávila, Ferney Arias, C Prakash Gyawali
{"title":"Hiatal Hernia and Conclusive Gastroesophageal Reflux Disease: Size Matters.","authors":"Juan S Hernández, Albis C Hani, Oscar M Muñoz, Juan P Garcia, Raúl A Cañadas, Freddy A Ávila, Ferney Arias, C Prakash Gyawali","doi":"10.5056/jnm26046","DOIUrl":"10.5056/jnm26046","url":null,"abstract":"<p><strong>Background/aims: </strong>: The Lyon Consensus considers hiatal hernia (HH) as a supportive metric for the diagnosis of gastroesophageal reflux disease (GERD) when evidence is inconclusive; however, HH size is not taken into consideration. We aimed to correlate HH size with conclusive evidence of GERD from multichannel intraluminal impedance and pH monitoring (MII-pH) and upper endoscopy.</p><p><strong>Methods: </strong>: We analyzed a retrospective consecutive cohort of patients with suspected GERD with and without HH on high-resolution manometry who also underwent upper endoscopy and MII-pH monitoring off therapy within a ≤6 month interval. HH was categorized as none, small (<3 cm), medium (3-5 cm), or large (>5 cm). Pathological acid exposure time (AET, >6%), endoscopic GERD findings, and adjunctive MII-pH metrics were compared and correlated between subsets based on the presence and size of HH.</p><p><strong>Results: </strong>: Of the 456 included patients, 337 (73.9%) had HH as follows: small HH, 114; medium HH, 117; and large HH, 106. Pathological AET showed a stepwise increase from 19.3% in the no HH group to 41.2% in the small HH group, 51.3% in the medium HH group, and 83.0% in the large HH group (<i>P</i> < 0.001). The prevalence of erosive esophagitis increased similarly (7.6%, 14.9%, 17.9%, and 43.4%, respectively; <i>P</i> < 0.001). DeMeester score, total reflux episodes (TREs), and mean nocturnal baseline impedance (MNBI) showed similar findings (all <i>P</i> < 0.001), but the prevalence of peptic stricture (<i>P</i> = 0.263) and Barrett's esophagus did not differ significantly (<i>P</i> = 0.108). HH size correlated positively with AET (rho = 0.49) and TRE (rho = 0.53) and negatively with MNBI (rho = -0.46; all <i>P</i> < 0.001).</p><p><strong>Conclusions: </strong>: Evidence for conclusive GERD increases with HH size, supporting its role as a key anatomical marker for GERD assessment using the Lyon Consensus 2.0 criteria.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":"32 4","pages":"549-556"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149298014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effectiveness and Patient Satisfaction With Zastaprazan in Real-World Practice: A Large-Scale Prospective Observational Study.","authors":"Seung In Seo, Kwang Hyun Ahn, Yong Sung Kim","doi":"10.5056/jnm26017","DOIUrl":"10.5056/jnm26017","url":null,"abstract":"<p><strong>Background/aims: </strong>: Gastroesophageal reflux disease (GERD) remains a prevalent condition with unmet therapeutic needs. Zastaprazan is a novel potassium-competitive acid blocker (P-CAB) with potent acid suppression, but real-world evidence is limited. This study assesses symptom improvement and patient satisfaction with zastaprazan in patients with GERD.</p><p><strong>Methods: </strong>: This multicenter, prospective observational study enrolled adults diagnosed with GERD who received zastaprazan 20 mg daily for 4 weeks. Symptoms were assessed using the Reflux Disease Questionnaire (RDQ). The primary endpoint was the change in the mean GERD score of the RDQ. Secondary endpoints included the mean total RDQ score, patient satisfaction, compliance, and effectiveness stratified by prior medication use and diagnostic method.</p><p><strong>Results: </strong>: Among 5499 participants, the mean GERD score significantly decreased from 2.07 ± 1.12 to 0.44 ± 0.63 at week 4 (change: -1.63 ± 1.07, <i>P</i> < 0.0001). Symptom improvement was observed in treatment-naïve patients (n = 4906, -1.64 ± 1.08, <i>P</i> < 0.0001) and those previously treated with histamine-2 receptor antagonists, proton pump inhibitors, or P-CABs (n = 593, -1.60 ± 1.03, <i>P</i> < 0.0001). The switching group (within 2 days) also showed significant improvement (n = 304, -1.53 ± 1.05, <i>P</i> < 0.0001). Over 90% reported satisfaction, compliance was 93%, and only 2.25% required concomitant medications. Safety was excellent, with only 3 cases of mild adverse reactions (0.05%) and no serious events.</p><p><strong>Conclusions: </strong>: Zastaprazan was associated with clinically meaningful symptom improvement in GERD patients, regardless of prior medication history, including proton pump inhibitors or other P-CABs, with high patient satisfaction, and a favorable safety profile.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":" ","pages":"655-663"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148840380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gut-Brain Axis-Mediated Neurological Manifestations in Inflammatory Bowel Disease: Mechanisms and Disease Spectrum.","authors":"Bingchan Sun, Guoxin Wang, Xiaoxia Li, Huimin Liu, Huan Xv, Qifang Wu, Hongtao Li, Xiangrong Ye, Xijin Wang, Mingfu Tong","doi":"10.5056/jnm25167","DOIUrl":"10.5056/jnm25167","url":null,"abstract":"<p><p>Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder of the gastrointestinal tract that is frequently associated with neuropsychiatric comorbidities, such as anxiety, depression, and other neurological disorders. Accumulating evidence suggests that these neuropsychiatric disorders are secondary conditions caused by impaired gut-brain communication. The gut-brain axis connects the gut and the brain via neural, endocrine, and immune signaling pathways, disruption of which is usually caused by intestinal microbiota imbalance, intestinal barrier damage, neuroinflammation and immune activation, and neuroendocrine pathway abnormalities. These pathways constitute the pathological basis of the disease spectrum of neuropsychiatric comorbidities in IBD patients. This article comprehensively reviews the core mechanisms and disease spectrum of gut-brain axis-mediated neurological and mental complications in IBD, and discusses potential therapeutic strategies and challenges.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":" ","pages":"476-492"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148900562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Eosinophilic Esophagitis in Asia: Distinct Clinical Phenotypes and Implications for Long-Term Management.","authors":"Kee Wook Jung, Evan S Dellon","doi":"10.5056/jnm26126","DOIUrl":"10.5056/jnm26126","url":null,"abstract":"<p><p>Eosinophilic esophagitis (EoE) has traditionally been regarded as a chronic, progressive inflammatory disorder associated with dysphagia, food impaction, and fibrostenotic remodeling. However, growing evidence from Asia suggests that EoE in Asian populations may exhibit distinct epidemiologic and clinical characteristics from those in Western cohorts. Recent studies from Asia have reported lower rates of fibrostenotic complications, greater responsiveness to proton pump inhibitors and potassium-competitive acid blockers, and a high prevalence of asymptomatic esophageal eosinophilia detected during routine screening endoscopy. Longitudinal studies have suggested that many Asian patients exhibit relatively mild inflammatory disease with limited progression, whereas severe fibrostenotic complications appear uncommon. Despite these phenotypic differences, molecular studies have indicated that the fundamental biology of EoE is largely conserved across geographic regions. These findings suggest that Asian and Western EoE likely represent the same underlying immune-mediated disease, with observed clinical differences potentially reflecting variation in disease stage at diagnosis, timing of diagnosis, healthcare systems, environmental exposures, and screening practices. Emerging data from Asia may also challenge the assumption that all patients with EoE inevitably require universal lifelong maintenance therapy. Current maintenance paradigms have largely been established from Western cohorts enriched for fibrostenotic disease and symptom-driven diagnosis, which may not fully represent the broader spectrum of EoE increasingly recognized in Asia. In this review, we summarize current evidence regarding geographic variation in EoE and discuss the potential implications of Asian disease phenotypes for individualized long-term management strategies.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":"32 4","pages":"534-540"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sung-Hoon Yoon, Dawoon Jung, Dae-Jin Kim, Chan-Mo Yang, Young Hyeon Ahn, June-Woo Kim, Yong-Sung Kim, Suck-Chei Choi, Sang-Yeol Lee
{"title":"Psychological Predictors of Symptom Severity in Disorders of Gut-Brain Interaction: A Machine Learning Approach.","authors":"Sung-Hoon Yoon, Dawoon Jung, Dae-Jin Kim, Chan-Mo Yang, Young Hyeon Ahn, June-Woo Kim, Yong-Sung Kim, Suck-Chei Choi, Sang-Yeol Lee","doi":"10.5056/jnm25246","DOIUrl":"10.5056/jnm25246","url":null,"abstract":"<p><strong>Background/aims: </strong>: Disorders of gut-brain interaction (DGBI) exhibit heterogeneous symptom burdens and psychosocial variability. We aimed to identify severity-based phenotypes via unsupervised clustering and evaluate the psychological factors independently associated with symptom severity using machine learning.</p><p><strong>Methods: </strong>: We analyzed 480 patients with DGBI who completed validated gastrointestinal symptom scales and a psychological battery assessing anxiety, depression, childhood trauma, social support, resilience, and Type D personality. K-means clustering (k = 2) yielded low-severity groups (n = 281) and high-severity groups (n = 199). Between-group differences were examined using Welch's t-test with false discovery rate (FDR) correction and Cohen's d. Five logistic regression models with different feature sets were compared under stratified 5-fold cross-validation. Feature importance was assessed via bootstrap odds ratios with 95% confidence intervals.</p><p><strong>Results: </strong>: The high-severity group showed significantly elevated anxiety and depressive symptoms (Cohen's d = 0.55-0.92 for the Beck Anxiety Inventory [BAI]; d = 0.56-0.63 for the Beck Depression Inventory) and higher childhood trauma scores on physical abuse, sexual abuse, and physical neglect subscales after FDR correction. The BAI-only model (area under the receiver operating characteristic curve [AUC] = 0.750) nearly matched the full 17-feature model (AUC = 0.753; accuracy = 71.3%; balanced accuracy = 69.9%), suggesting that the incremental contribution of multidimensional psychological profiling beyond anxiety assessment alone was limited.</p><p><strong>Conclusions: </strong>: Anxiety symptoms, particularly somatic and physiological dimensions, are the primary psychological determinants of DGBI severity. Childhood trauma associations are likely to operate through anxiety and depression pathways. These findings support routine somatic anxiety screening in gastroenterology to identify candidates for brain-gut behavioral therapies.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":"32 4","pages":"565-576"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149298060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yuhao Song, Jian Wang, Wenyu Zhang, Tianxing Li, Yanan Mao, Jiande D Z Chen, Lei Liang, Weifen Xie, Beifang Ning
{"title":"Effects of Needleless Transcutaneous Electrical Acustimulation on Gastrointestinal Function Recovery After Multi-Level Lumbar Surgery: A Randomized Clinical Trial.","authors":"Yuhao Song, Jian Wang, Wenyu Zhang, Tianxing Li, Yanan Mao, Jiande D Z Chen, Lei Liang, Weifen Xie, Beifang Ning","doi":"10.5056/jnm25261","DOIUrl":"10.5056/jnm25261","url":null,"abstract":"<p><strong>Background/aims: </strong>: Postoperative gastrointestinal dysfunction is a common complication of spinal surgery. This study aimed to determine the effect of transcutaneous electrical acustimulation (TEA) on the recovery of postoperative gastrointestinal function in patients undergoing lumbar surgery and to explore the underlying mechanism.</p><p><strong>Methods: </strong>: Fifty patients undergoing multi-level (n ≥ 2) lumbar surgery were randomly assigned to receive TEA or sham-TEA treatment for 1 hour twice daily from postoperative day (POD)1 to POD3. Zusanli (ST36) and Neiguan (PC6) were selected as the stimulation points for the TEA group. The time to first flatus and defecation after surgery and other outcome measures were recorded. Gastric slow waves (GSW) were detected using an electrogastrogram, and autonomic function was assessed by analyzing heart rate variability derived from electrocardiogram recordings. Serum levels of interleukin (IL)-6, serotonin, and norepinephrine (NE) were also examined.</p><p><strong>Results: </strong>: Compared with sham-TEA, TEA significantly shortened the time to first flatus (<i>P</i> < 0.001) and defecation (<i>P</i> < 0.05) and reduced gastrointestinal symptom scores (<i>P</i> < 0.01). TEA increased the percentage of normal GSW (<i>P</i> < 0.05) and vagal activity (<i>P</i> < 0.001) postoperatively. Compared with POD1, TEA decreased the levels of IL-6, serotonin, and NE on POD4. Additionally, vagal activity on POD4 was negatively correlated with the time to first flatus (r = -0.383, <i>P</i> = 0.009). TEA treatment was identified as a factor independently associated with the time to first postoperative flatus and defecation.</p><p><strong>Conclusions: </strong>: Needleless TEA is probably associated with accelerated recovery of gastrointestinal function after lumbar surgery, possibly through the modulation of autonomic activity.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":"32 4","pages":"644-654"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elise M Wessels, Niek Warringa, Gwen M C Masclee, Pietro Familiari, Albert J Bredenoord
{"title":"Reflux and Other Esophageal Acidification Patterns in Achalasia Patients With Reflux Esophagitis After Peroral Endoscopic Myotomy.","authors":"Elise M Wessels, Niek Warringa, Gwen M C Masclee, Pietro Familiari, Albert J Bredenoord","doi":"10.5056/jnm26006","DOIUrl":"10.5056/jnm26006","url":null,"abstract":"<p><strong>Background/aims: </strong>: Peroral endoscopic myotomy (POEM) is an effective and safe treatment for patients with achalasia; however, it is associated with reflux esophagitis after treatment. This study aimed to examine underlying acidification patterns in patients with achalasia with reflux esophagitis after POEM.</p><p><strong>Methods: </strong>: Data were used from a large multicenter randomized controlled trial comparing the effects of POEM and pneumatic dilation in treatment of naive patients with achalasia. Gastroduodenoscopy and 24-hour pH-impedance testing were performed 1 year post-POEM. Acid exposure time (AET), mean pH, minimum pH, and acidification patterns such as reflux, acid fermentation and stasis of acidic foods were compared between patients with endoscopically proven gastroesophageal reflux disease (GERD; LA grade B-D) and those without.</p><p><strong>Results: </strong>: In total 38 patients were included of which 9 had endoscopically proven GERD (23.7%). AET and mean pH levels were not different between patients with and without proven GERD (14.5% vs. 6.0%, <i>P</i> = 0.636 and 5.4 vs. 5.2, <i>P</i> = 0.747, respectively). Patients with reflux esophagitis grade B-D reached lower minimum pH (1.5 vs. 2.1, <i>P</i> = 0.024) and had significantly longer episodes of reflux with delayed clearance, particularly in the supine position (7.7% vs. 0.0%, <i>P</i> = 0.041). Acid fermentation was seen in a large proportion of patients, but was not significantly different between patients with and without proven GERD (10.2% vs. 0.4%, <i>P</i> = 0.343).</p><p><strong>Conclusions: </strong>: Reflux with delayed clearance in supine position appeared to be the dominant acidification pattern in patients with achalasia and reflux esophagitis after POEM.</p>","PeriodicalId":16543,"journal":{"name":"Journal of Neurogastroenterology and Motility","volume":"32 4","pages":"607-614"},"PeriodicalIF":3.7,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149298083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}